Using database linkages to monitor the continuum of care for hepatitis C virus among syringe exchange clients: Experience from a pilot intervention.
Using database linkages to monitor the continuum of care for hepatitis C virus among syringe exchange clients: Experience from a pilot intervention.
复制标题
使用数据库链接监测注射器交换客户中丙型肝炎病毒护理的连续性：试点干预的经验。
DOI：
10.1016/j.drugpo.2016.12.006
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
Westergaard,RyanP
中科院分区：
文献类型：
--
作者：
Hochstatter,KarliR;Hull,ShawnikaJ;Stockman,LaurenJ;Stephens,LauraK;Olson-Streed,HeidiK;Ehlenbach,WilliamJ;Repplinger,MichaelD;Jacobs,ElizabethA;Westergaard,RyanP
Increased incidence of hepatitis C virus (HCV) infection has been recently detected in many nonurban areas of the US (Centers for Disease Control and Prevention [CDC], 2012; Conrad et al., 2015, Zibbell et al., 2015). Driven primarily by injection drug use, this acceleration of the HCV epidemic has come during a period of rapid improvement in the efficacy and tolerability of anti-HCV therapy. Despite projections that HCV incidence could be markedly reduced with scale-up of direct-acting antiviral treatment, uptake of treatment among people who inject drugs (PWID) has remained low at an estimated 2–4%(Echevarria et al., 2015, Harris and Rhodes, 2013). Developing strategies to optimise the so called “HCV care continuum,” wherein HCV-infected individuals are screened, receive RNA confirmatory testing, get linked to care, undergo pretreatment evaluation, initiate antiviral treatment and are ultimately cured (Holmberg, Spradling, Moorman, & Denniston, 2013), is an important public health priority.Viral hepatitis surveillance plays an important role in understanding the burden of HCV in communities (CDC, 1998). Requirements for clinicians and laboratories to report diagnoses of HCV to state and local health departments serve as the backbone of HCV surveillance. Surveillance data allow jurisdictions to estimate the prevalence of known HCV cases and to detect trends in incidence, but have important limitations. Of the estimated 3.2 million persons chronically infected with HCV in the US, approximately half remain undiagnosed, and are consequently unaccounted for in surveillance systems (American Association for the Study of Liver Diseases and the Infectious Diseases Society of America [AASLD and IDSA], 2015). Because many individuals at high risk of HCV, especially young PWID, have poor access to medical care, surveillance programs’ reliance on clinician and laboratory-based reporting may systematically under-represent key populations.
影响因子：
4.5
作者：
Harris PA;Taylor R;Thielke R;Payne J;Gonzalez N;Conde JG
通讯作者：
Conde JG